Ropes & Gray represented Avista Healthcare Partners, while Foley Hoag represented Organogenesis Holdings, Inc. in the transaction. Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented 1440 Foods in the transaction, and Finn Dixon & Herling represented FITCRUNCH and Bakery Barn. 1440 Foods, a portfolio of sports and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented CAMP4 Therapeutics in the transaction, and Paul Hastings represented the underwriters. CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company, announced...
You must be a Standard 1 Year member to access this content.
Maples and Calder acted as British Virgin Islands counsel to Biohaven Ltd. in the offering, and Sullivan & Cromwell acted as New York counsel and Ropes...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Berkshire Partners in the transaction. Berkshire Partners (“Berkshire”) announced its strategic investment alongside Leonard Green & Partners (“Linden”) in Vital Care, an...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented TSG Consumer Partners in the transaction, and Cooley represented Summer Fridays. TSG Consumer Partners announced its investment in Summer Fridays, a clean,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Amylyx Pharmaceuticals in the transaction and Sidley Austin represented Eiger BioPharmaceuticals. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx) announced the acquisition of a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Foghorn Therapeutics Inc. on the offering, and Latham & Watkins advised the underwriters. Foghorn Therapeutics Inc. (Nasdaq: FHTX) (“Foghorn”), a clinical-stage biotechnology...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Dessert Holdings in the transaction, and Holland & Knight represented Kenny’s Great Pies. Dessert Holdings®, North America’s premium dessert company, announced that...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
You must be a Standard 1 Year member to access this content.
Maples and Calder acted as British Virgin Island counsel to Biohaven Ltd., and Sullivan & Cromwell acted as US counsel, while Ropes & Gray represented the...
You must be a Standard 1 Year member to access this content.
